Combining data analytics and healthcare raises interesting questions of ethics. In a context where consumer data are an increasingly valuable currency globally and concerns for individual privacy becomes widespread, what is 23andMe’s situation?
consumer genomics
23andMe: Current personal genomics market leader turned market loser?
Pivotal decision to not invest in new genetic technology to undercut 23andMe’s future position in the consumer genomics space